Up 160% in a year, why this ASX 200 healthcare stock is surging again today

Pro Medicus Limited (ASX: PME) shares are having a good start to the session. In morning trade, the ASX 200 …

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are having a good start to the session.

In morning trade, the ASX 200 healthcare stock is up 3% to $261.50.

This builds on the 160% gain the health imaging technology company's shares had already recorded over the past 12 months.

Why is this ASX 200 healthcare stock surging?

Investors have been bidding the Pro Medicus share price higher today for a couple of reasons.

One reason is that Wall Street rallied higher overnight thanks to the release of favourable inflation data. This is giving the whole market a big boost this morning.

In addition, investors are responding positively to the release of an announcement from the ASX 200 healthcare stock today.

According to the release, the company has signed a $33 million, 9-year contract with the University of Kentucky (UK). It is the preeminent academic health system in the state of Kentucky.

The company notes that UK HealthCare is a comprehensive healthcare system that includes a network of hospitals, clinics, and specialised medical services. It is anchored by the UK Albert B. Chandler Hospital, which is a leading medical facility in the region, offering advanced treatment options and cutting-edge research.

It also highlights that the system includes the UK Good Samaritan Hospital, which provides a range of services including emergency care, surgery, and rehabilitation. Furthermore, it is affiliated with the University of Kentucky College of Medicine, ensuring a strong emphasis on education, research, and innovation.

What's the contract?

The release reveals that the contract is based on a transactional licensing model and will see the company's cloud-based Visage 7 Enterprise Imaging Platform, including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout UK providing a unified diagnostic imaging platform.

Visage will complete the migration from UK's legacy PACS archive and vendor neutral archive to Visage 7 Open Archive. Visage 7 will also provide enterprise distribution of images integrated to UK's electronic health record (EHR).

Commenting on this latest contract win, the ASX 200 healthcare stock's CEO, Dr Sam Hupert, said:

University of Kentucky joins our growing list of academic clients. They also join a long list of Visage 7 clients to opt for a fully cloud-based solution, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market.

Our pipeline remains strong and spans all market segments. As has been the case with many of our recent contracts, this deal is for our "full stack" comprising all three Visage products namely viewer, workflow and archive, a trend we see continuing.

Should you invest $1,000 in Pro Medicus right now?

Before you buy Pro Medicus shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Pro Medicus wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

ASX shares Business man marking buy on board and underlining it
Broker Notes

10 ASX shares to buy after the market selloff

Analysts think these shares could be strong buys after recent weakness. Let's see what they are recommending.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was carnage on the ASX today.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

ASX 200 plunges as US tariffs fall-out continues

The ASX 200 benchmark index fell by almost 200 points on Friday.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Opinions

ASX shares are on sale! What are you buying?

Stocks are being hit hard. There are opportunities everywhere.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in April

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

woman holding 'hiring' sign in shop
Share Market News

Why is tonight's US jobs report so significant for global markets?

With Liberation Day in the rearview mirror, global equity markets will be looking towards tonight's US jobs data.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX 200 shares rocketing higher in this month's falling market

A handful of ASX 200 shares managed to fly higher this past month. But how?

Read more »

Man looking happy and excited as he looks at his mobile phone.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »